# TriplePoint Venture Growth BDC (TPVG)

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-29  
**Report type:** Primer (steps 1–3 of 19)  
**API endpoint:** GET /api/v1/research/TPVG/primer

## Business Model

---
source: coverage-next-full | ticker: TPVG | step: "01" | created: 2026-05-29
---

### Step 01 — Business Overview: TPVG (TriplePoint Venture Growth BDC Corp.)

#### Executive Summary

TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) is a specialty finance company that has elected to be regulated as a Business Development Company (BDC) under the Investment Company Act of 1940. TPVG is externally managed by TriplePoint Capital LLC, a leading venture lending firm founded in 2012 by Jim Labe and Sajal Srivastava — the same team that previously built the venture lending practice at Lighthouse Capital Partners and then at Comerica Bank's venture lending division.

**The core value proposition:** TPVG provides debt capital (primarily term loans) to venture-backed, growth-stage technology and life science companies that are pre-profitability and therefore unable to access traditional bank financing or capital markets. In exchange, TPVG earns premium interest rates (typically 11–15% cash + 1–3% PIK) and receives equity "kickers" in the form of warrants on borrower stock — providing participation in equity upside if a portfolio company achieves a successful exit (IPO or M&A).

#### What Makes TPVG Unique Among BDCs

TPVG is a **pure-play venture lending BDC** — the only publicly traded BDC almost exclusively focused on VC-backed growth-stage companies. This contrasts with:
- **Hercules Capital (HTGC):** Similar strategy but broader sector coverage, larger scale (~$4B assets vs. TPVG ~$800M–$1B), and internally managed (cost advantage)
- **Traditional BDCs (ARCC, MAIN, GBDC):** Middle market lending to profitable companies; lower yield but lower credit risk
- **Silicon Valley Bank (SIVB):** Was the dominant venture lending bank; its March 2023 collapse removed a major competitor and briefly created significant opportunity for TPVG/HTGC

#### Business Model

##### Revenue Generation
1. **Interest Income (~85–90% of revenue):** Floating rate loans (SOFR/Prime + spread) plus fixed floors, generating 12–16% gross yields on the debt portfolio
2. **Fee Income (~5–8%):** Origination fees, prepayment fees, end-of-term (EOT) payments
3. **Dividend/Equity Income (<5%):** From equity co-investments alongside debt
4. **Warrant Gains (variable):** Fair value adjustments and realized gains on warrants received at origination; highly lumpy and dependent on portfolio company exits

##### The Venture Lending Thesis
- VC-backed companies have strong institutional sponsors (Sequoia, a16z, Benchmark, etc.) with incentive to support companies through difficulty
- Loan-to-value ratios are implicitly low because enterprise value of growth companies often far exceeds outstanding venture debt
- Warrants provide a "free" equity kicker: TPVG receives warrants for 1–5% of a borrower's fully diluted equity at the time of lending
- Post-money valuations from VC rounds provide reference points for NAV marks

#### Headquarters & Personnel

- **HQ:** 2755 Sand Hill Road, Menlo Park, CA 94025 (Silicon Valley heartland; same road as Sequoia, KKR, KPCB, etc.)
- **Investment Manager:** TriplePoint Capital LLC (external manager — NOT employees of TPVG)
- **CEO:** James P. Labe — co-founder of TriplePoint Capital; previously built venture lending at Lighthouse Capital Partners (1997–2006) and Comerica (2006–2012). Widely regarded as one of the original architects of institutional venture lending
- **President/COO:** Sajal Srivastava — co-founder; former president of venture banking at Lighthouse Capital; Stanford MBA

#### Portfolio Characteristics

| Characteristic | Typical Range |
|----------------|---------------|
| Number of Portfolio Companies | 30–55 active |
| Loan Size per Company | $5M–$50M |
| Loan Tenor | 24–48 months |
| Interest Rate | SOFR + 700–1,000 bps (typically 11–15% all-in) |
| PIK Component | 0–3% |
| Warrant Coverage | 1–5% of fully diluted equity |
| Industries | Technology (SaaS, fintech, marketplace), life sciences, consumer |
| Geography | ~95% US; small amount of international VC-backed companies |

#### Investment Selection Criteria

TPVG/TriplePoint Capital targets companies that:
1. Are backed by top-tier VC firms (Tier 1 sponsors)
2. Have achieved product-market fit and are in growth/scale phase
3. Have 12–18 months of cash runway remaining after the loan
4. Have a clear path to a liquidity event (IPO, strategic M&A, or next VC round)
5. Operate in sectors with strong secular tailwinds

#### IPO History & Capital Structure

- **IPO:** March 5, 2014 at $15.00/share; raised approximately $90M
- **Total shares outstanding (2024):** ~33–35 million
- **Market cap (2024):** ~$300–$400M depending on share price
- **Total net assets (NAV):** ~$430–$460M at peak; declined to ~$400M range by 2024
- **External borrowings:** Senior secured notes, revolving credit facility — targeting 0.8–1.0x debt/equity

#### Key Differentiators vs. HTGC

| Factor | TPVG | HTGC |
|--------|------|------|
| Management | External (fee conflicts) | Internal (aligned) |
| AUM | ~$800M–$1B | ~$3.5B–$4B |
| Diversification | Narrower (pure venture) | Broader (life sci, tech, sustainable) |
| Track record | Shorter (2014 IPO) | Longer (2005 IPO) |
| NAV stability | More volatile | More stable |
| Yield | Similar | Similar |
| P/NAV | Typically lower | Typically closer to 1x |

## Financial Snapshot

---
source: coverage-next-full | ticker: TPVG | step: "04" | created: 2026-05-29
---

### Step 04 — Financial Snapshot: TPVG (FY2021–FY2024)

#### Key Financial Summary — Annual

| Metric | FY2021 | FY2022 | FY2023 | FY2024E |
|--------|--------|--------|--------|---------|
| Total Investment Income ($M) | ~$85M | ~$105M | ~$115M | ~$100M |
| Net Investment Income ($M) | ~$52M | ~$64M | ~$65M | ~$56M |
| NII per Share | ~$1.56 | ~$1.95 | ~$1.97 | ~$1.65 |
| Net Increase in Net Assets ($M) | ~$55M | -~$75M | -~$60M | -~$30M |
| Total Dividends Declared per Share | $1.44 | $1.44 | $1.56 | $1.44 |
| Net Asset Value per Share | ~$15.00 | ~$13.25 | ~$12.50 | ~$12.00 |
| Total Net Assets ($M) | ~$494M | ~$437M | ~$410M | ~$393M |
| Total Investments at Fair Value ($M) | ~$940M | ~$970M | ~$820M | ~$760M |
| Debt/Equity Ratio | ~0.92x | ~1.04x | ~0.88x | ~0.80x |
| Shares Outstanding (M) | ~33.0 | ~33.0 | ~32.8 | ~32.7 |

*Note: FY2024E figures are estimates based on available quarterly data and management guidance. Exact figures subject to final 10-K filing.*

#### NAV Per Share Trajectory — The Central Concern

NAV/share is the most important metric for BDC investors. TPVG's NAV/share has exhibited a structurally declining trend:

| Period | NAV/Share | Quarterly Change | Driver |
|--------|-----------|-----------------|--------|
| Q4 2020 | ~$14.50 | — | COVID recovery |
| Q4 2021 | ~$15.00 | +3.4% | VC boom; warrant appreciation |
| Q1 2022 | ~$14.50 | -3.3% | Tech selloff; initial marks |
| Q2 2022 | ~$14.00 | -3.4% | Continued VC valuation pressure |
| Q3 2022 | ~$13.50 | -3.6% | Portfolio write-downs accelerate |
| Q4 2022 | ~$13.25 | -1.9% | Non-accruals rising |
| Q1 2023 | ~$13.00 | -1.9% | SVB crisis; sector stress |
| Q2 2023 | ~$12.75 | -1.9% | Elevated non-accruals |
| Q3 2023 | ~$12.50 | -2.0% | Realized losses from failures |
| Q4 2023 | ~$12.50 | flat | Stabilization |
| Q1 2024 | ~$12.25 | -2.0% | Continued mild pressure |
| Q2 2024 | ~$12.00 | -2.0% | Slow recovery trajectory |
| Q3 2024 | ~$12.00 | flat | Signs of stabilization |
| Q4 2024E | ~$12.00 | flat | Stable |

**Key observation:** TPVG has eroded approximately $3.00/share (~20%) in NAV since peak. This represents permanent capital loss not reflected in income statement performance alone.

#### Net Investment Income vs. Dividends — Coverage Analysis

| Year | NII/Share | DPS Declared | Coverage Ratio | Status |
|------|-----------|-------------|---------------|--------|
| 2021 | ~$1.56 | $1.44 | 108% | Covered; building spillover |
| 2022 | ~$1.95 | $1.44 | 135% | Well covered; benefit of rising rates |
| 2023 | ~$1.97 | $1.56 | 126% | Well covered; dividend raised in 2023 |
| 2024E | ~$1.65 | $1.44 | 115% | Still covered but tightening |

**Dividend history:**
- 2014–2019: $1.44/share annual ($0.36/quarter) — paid quarterly
- 2020 (COVID): Dividend cut from $0.36 → $0.31/quarter
- 2021 recovery: Returned to $0.36/quarter ($1.44/year)
- 2023: Increased to $0.39/quarter (+ special dividends in some quarters)
- 2024: Returned to $0.36/quarter as portfolio income declined with portfolio payoffs

TPVG adopted a **monthly dividend** structure in later years ($0.12–$0.13/month) to better match BDC cash flow patterns.

#### Income Statement Detail (FY2023 — Most Recent Full Year)

| Line Item | Amount |
|-----------|--------|
| Interest income (cash) | ~$95M |
| PIK interest income | ~$8M |
| Fee income | ~$10M |
| Dividend income | ~$2M |
| **Total Investment Income** | **~$115M** |
| Management fees (base) | (~$17M) |
| Incentive fees (Part 1) | (~$9M) |
| Interest and debt fees | (~$20M) |
| Other operating expenses | (~$4M) |
| **Total Expenses** | **(~$50M)** |
| **Net Investment Income** | **~$65M** |
| Net realized losses | (~$35M) |
| Net change in unrealized | (~$25M) |
| **Net Decrease in Net Assets** | **(~$60M)** |

#### Balance Sheet Snapshot (FY2023)

| Item | Amount |
|------|--------|
| Total investments at fair value | ~$820M |
| Cash and equivalents | ~$20M |
| Other assets | ~$5M |
| **Total Assets** | **~$845M** |
| Senior secured notes (public) | ~$180M |
| Revolving credit facility | ~$240M |
| Other liabilities | ~$15M |
| **Total Liabilities** | **~$435M** |
| **Net Assets (NAV)** | **~$410M** |
| Shares outstanding | ~32.8M |
| **NAV per Share** | **~$12.50** |

#### Portfolio Quality Metrics

| Metric | FY2021 | FY2022 | FY2023 | FY2024E |
|--------|--------|--------|--------|---------|
| Non-accrual loans (% fair value) | ~1.5% | ~3.0% | ~5.5% | ~6.0% |
| Non-accrual loans (% cost) | ~2.0% | ~4.5% | ~8.0% | ~8.5% |
| Number of portfolio companies | ~50 | ~55 | ~48 | ~42 |
| New commitments ($M) | ~$650M | ~$700M | ~$400M | ~$350M |
| Portfolio repayments ($M) | ~$450M | ~$580M | ~$550M | ~$380M |

#### Valuation Context

| Metric | Historical Range | Current (2024) |
|--------|-----------------|----------------|
| Price / NAV | 0.7x – 1.1x | ~0.80–0.90x |
| Dividend Yield | 7% – 14% | ~10–12% |
| P/NII | 7x – 12x | ~8–9x |

**Trading at a discount to NAV** is normal for BDCs facing elevated credit stress. TPVG has consistently traded below HTGC's premium, reflecting the external management fee structure and higher portfolio risk perception.

#### Key Financial Risks to Track

1. **NAV erosion:** The $3/share decline since 2021 peak is permanent capital loss — not cyclical
2. **Non-accrual creep:** Every 1% increase in non-accrual rate costs ~$8–$10M in foregone annual income
3. **Leverage headroom:** At 0.8–1.0x debt/equity, TPVG has limited ability to grow without dilutive equity issuance
4. **Dividend sustainability:** NII coverage has improved with rising rates but could fall if portfolio shrinks or rates decline
5. **Fair value volatility:** Mark-to-market adjustments on Level 3 assets can cause large quarter-to-quarter NAV swings

## Recent Catalysts

---
source: coverage-next-full | ticker: TPVG | step: "12" | created: 2026-05-29
---

### Step 12 — Catalysts: TPVG

#### Near-Term Catalysts (0–12 Months)

##### 1. Non-Accrual Resolution

The single most impactful near-term catalyst is resolution of the current non-accrual book. Each non-accrual loan that is either restructured back to paying status, paid off through a portfolio company M&A, or written off and removed from the balance sheet:
- If resolved positively (paid off/restructured): Immediate income recovery; potential realized gain; NAV stabilization
- If written off: Clean slate effect — removes overhang; future quarters show higher coverage ratios
- **Timeline:** Ongoing; typical workout period for stressed VC-backed companies is 6–18 months

##### 2. Portfolio Stabilization and Re-Growth

TPVG's portfolio has declined from ~$970M (Q4 2022) to ~$760M (Q3 2024):
- **Catalyst trigger:** New commitments persistently exceeding repayments; portfolio begins growing
- **Effect:** Reverses NII compression; demonstrates manager confidence in deal quality; could trigger P/NAV multiple expansion
- **Timeline:** Q4 2024–Q2 2025; AI lending boom could accelerate

##### 3. VC Market Strengthening

If the VC funding environment continues to recover in 2025:
- More portfolio companies receive follow-on funding → fewer non-accruals
- Existing warrant/equity investments appreciate as company valuations rise
- New deal flow improves in both quality and quantity
- **Catalyst trigger:** Top-tier VC fund performance reports; IPO window reopening (Stripe, Databricks, Plaid, etc.)
- **Timeline:** 2025 VC season; major AI company IPOs

##### 4. Dividend Maintenance / Small Increase

- TPVG returning to $0.13/month (from current $0.12) would signal management confidence in earnings power
- Even maintaining the $0.12/month signals stability to yield-focused investors
- **Timeline:** Monthly announcements; watch for special dividends if spillover builds

##### 5. Rate Stabilization

- Fed pausing rate cuts would protect NII from further compression
- If market pricing turns rate-stable or slightly higher, floating-rate portfolio benefits accrue
- **Timeline:** FOMC meetings; Fed communication on terminal rate

#### Medium-Term Catalysts (1–3 Years)

##### 6. Major Warrant Monetization Event

The AI investment boom of 2023–2025 is creating companies that will ultimately go public or be acquired:
- If one or more TPVG portfolio companies with large warrant positions exit at premium valuations, warrant gains could be $10–$50M+ in a single year
- Historical: In 2021, warrant gains added ~$0.75/share to total return
- **Trigger:** IPO wave for AI-native companies; strategic acquisitions in tech
- **Timeline:** 2025–2027 for AI-era IPO cycle

##### 7. SVB Replacement Thesis Plays Out

TPVG is positioned as a primary beneficiary of the SVB void:
- As institutional trust returns to specialty venture lenders (vs. banks), TPVG could grow to $1.2–1.5B in AUM
- Larger portfolio → more NII → higher dividend coverage → potential dividend increase
- **Timeline:** 2025–2027

##### 8. Internalization Optionality

While speculative, if TriplePoint Capital were to internalize TPVG management (common in maturing BDC stories):
- Fee drag of ~$22M/year disappears
- P/NAV discount vs. HTGC would narrow
- Could be worth $2–3/share in NAV equivalent
- **Timeline:** Uncertain; requires board and shareholder action; not currently on management's stated agenda

#### Negative Catalysts (Downside Risks)

##### 9. Dividend Cut

- If NII coverage falls below ~100% and spillover is insufficient, a dividend cut becomes necessary
- Would likely trigger significant selling from income-focused investors
- Could compress P/NAV further from already-discounted levels

##### 10. Prolonged Non-Accrual Escalation

- If non-accruals rise from ~8.5% to 12–15% of portfolio cost, NAV could decline another $2–3/share
- Triggered by: Further VC funding contraction, macro recession, AI bubble burst

##### 11. Refinancing Shock

- 2025 and 2026 note maturities at higher rates could increase interest expense by $6M+/year
- Combined with declining NII, dividend coverage could fall below 100%

---

**Bull Case**
- The 2022–2023 VC correction has passed its worst point and non-accruals have peaked; TPVG's $0.86x P/NAV discount resolves as portfolio quality becomes visible, AI investment boom drives record new commitments, and warrant monetization from an AI-era IPO cycle adds $0.50–$1.00/share in gains; 2–3 year total return of 30–45% (dividends + NAV recovery + P/NAV re-rating)
- SVB's permanent exit from venture lending and TPVG's strong VC sponsor relationships position it to grow AUM from ~$760M toward $1.2B; a larger portfolio with improved credit quality restores NII coverage to 130%+ and enables a dividend increase to $1.56/year or higher
- A potential internalization of management (eliminating ~$22M/year in external fees) would immediately add ~$2/share in NAV equivalent and close the P/NAV gap to HTGC's premium valuation (~1.0–1.1x NAV)

**Bear Case**
- Non-accruals remain elevated at 8–10% of portfolio cost through 2025–2026, as VC-backed companies continue to fail in a higher-for-longer rate environment; realized credit losses erode NAV to $9–$10/share and force a 20–25% dividend cut that re-prices the stock at an even wider discount
- The competitive moat that TPC once held is structurally eroded by bank competition (JP Morgan, HSBC Innovation Banking, Western Alliance) offering lower rates post-SVB, compressing new loan spreads and reducing deal flow; TPVG's premium portfolio yield normalizes toward 12–13% all-in vs. ~17% today
- External management fee structure (1.75% on gross assets) proves terminal: as interest rates decline and portfolio yield compresses, the NII margin is squeezed between falling income and fixed fee extraction, making TPVG uninvestable relative to HTGC at any reasonable P/NAV without a management structure change that management shows no intention of pursuing

## Full Research Available

This primer covers steps 1–3 of 19. The full deep dive (moat analysis, DCF, bull/bear,
management quality, earnings transcript analysis) is available via:

- Investment memo: /memo/tpvg
- Full research API: GET /api/v1/research/TPVG/memo
- Coverage universe: /stocks